Source:http://linkedlifedata.com/resource/pubmed/id/11553467
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9
|
pubmed:dateCreated |
2001-9-12
|
pubmed:abstractText |
An important question in the study of ligand-DNA interactions is the determination of binding specificity. Here, we used the combinatorial method restriction endonuclease protection, selection, and amplification (REPSA) to identify the preferred duplex DNA-binding sites of the antineoplastic agent actinomycin D. After 10 rounds of REPSA, over 95% of the cloned DNAs exhibited significantly reduced FokI restriction endonuclease cleavage in the presence of 1 microM actinomycin. A chi(2) statistical analysis of their sequences found that 39 of the 45 clones contained one or more copies of the sequence 5'-(T/A)GC(A/T)-3', giving a p<0.001 for this consensus. A DNase I footprinting analysis of the cloned DNAs found that all possessed relatively high affinity actinomycin-binding sites with apparent dissociation constants between 12 and 258nM (average 98nM). The average footprint encompassed 7.6 bases and in most cases (90%) included one or more consensus sequences. Interestingly, several of the selected clones contained overlapping consensus sequences (e.g., 5'-TGCTGCT-3'), suggesting that such close proximity DNA-binding sites may actually be preferred by actinomycin under physiological conditions.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/DNA,
http://linkedlifedata.com/resource/pubmed/chemical/DNA Restriction Enzymes,
http://linkedlifedata.com/resource/pubmed/chemical/DNA-Binding Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Dactinomycin,
http://linkedlifedata.com/resource/pubmed/chemical/Deoxyribonuclease I,
http://linkedlifedata.com/resource/pubmed/chemical/Nucleic Acid Synthesis Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/Oligonucleotides
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0968-0896
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
9
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2285-93
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11553467-Base Sequence,
pubmed-meshheading:11553467-Binding Sites,
pubmed-meshheading:11553467-Cloning, Molecular,
pubmed-meshheading:11553467-Consensus Sequence,
pubmed-meshheading:11553467-DNA,
pubmed-meshheading:11553467-DNA Footprinting,
pubmed-meshheading:11553467-DNA Restriction Enzymes,
pubmed-meshheading:11553467-DNA-Binding Proteins,
pubmed-meshheading:11553467-Dactinomycin,
pubmed-meshheading:11553467-Deoxyribonuclease I,
pubmed-meshheading:11553467-Kinetics,
pubmed-meshheading:11553467-Models, Molecular,
pubmed-meshheading:11553467-Nucleic Acid Synthesis Inhibitors,
pubmed-meshheading:11553467-Oligonucleotides
|
pubmed:year |
2001
|
pubmed:articleTitle |
Identification of preferred actinomycin-DNA binding sites by the combinatorial method REPSA.
|
pubmed:affiliation |
Department of Molecular and Cellular Oncology, Box 79, University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030-4009, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|